Search clinical trials for: IMC-R117C

Total 258 results

Eli Lilly and Company

Completed

An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma

Malignant Melanoma

United States
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
RenJi Hospital; The First Affiliated Hospital of Nanyang Medical College; ImmuneCare...

Recruiting

A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.

Atherosclerosis

China
ImmuneOncia Therapeutics Inc.

Completed

A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas

Lymphoma | Solid Tumor

Korea, Republic of, United States
Immunocore Ltd

Not yet recruiting

Study of IMC-S118AI in Type 1 Diabetes

Type 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
Immunocore Ltd

Recruiting

Study of IMC-P115C in Advanced PRAME-Positive Cancers

Cancer | PRAME Positive | HLA-A*02:01-positive

Spain, France, Italy, Australia

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe